CIHP Projects Portfolio

0

States

0

Projects

0

Health Facilities

0

Beneficiaries reached

0

Years in service

Interactive Project Timeline

IRIS Project

5-year HIV program across Kaduna, Kogi & Lagos.

AEARI Project

Accelerating RMNCH innovations & reforms in Lagos State.

Newborn Bundled Care

Support to Newborn Unit for scale-up of newborn care innovations.

REACH-OUT Project

Zero-dose immunization strategies across Nigeria, Kenya & Rwanda.

IMPAACT4HIV

Pediatric AHD care & STOP AIDS package implementation.

Ongoing Projects

Ongoing

IRIS Project (Innovate, Recalibrate, Integrate, and Surge)

Innovate, Recalibrate, Integrate, and Surge — HIV Program (Oct 2022 – Sep 2027)

The IRIS (Innovate, Recalibrate, Integrate, and Surge) project is a five-year (October 2022 – September 2027) comprehensive HIV program funded by PEPFAR through the US Centers for Disease Control (CDC). CIHP is currently implementing the IRIS project in Kaduna, Kogi, and Lagos States. IRIS is grounded in the strategic use of service delivery innovation and data, leveraging both established and novel approaches to identify and reach populations at risk of HIV infection to access HIV testing services. The project also employs evidence-based interventions to sustain persons living with HIV on treatment, strengthen resilient and integrated health systems, while fast-tracking progress toward HIV epidemic control in the country.

At inception, the project spanned four states, including Gombe. However, in June 2024, implementation in Gombe was successfully transitioned to the Global Fund sub-recipient and the State Government, a strategic shift aimed at program alignment for sustainability and ownership.

Ongoing

AEARI Project (Accelerating the Expanded Adoption of RMNCH Innovations and Health Reforms)

Accelerating the Expanded Adoption of RMNCH Innovations & Health Reforms (Dec 2023 – Dec 2027)

CIHP is implementing the Accelerating the Expanded Adoption of RMNCH (Reproductive, Maternal, Newborn, and Child Health) Innovations and Health Reforms (AEARI) project with funding from the Gates Foundation through TA Connect. This four-year (December 2023 -December 2027) technical assistance grant aims to strengthen the uptake and scale-up of nationally adopted Maternal and Newborn Health (MNH) innovations and services along the spectrum of care in Lagos State.

The AEARI project focuses on reducing maternal and newborn mortality by prioritizing the adoption of the MNH innovations: Multi-Micronutrient Supplementation + Calcium (MMS Plus Calcium), Maternal Azithromycin, and the use of Postpartum Hemorrhage (PPH) Bundle.

Ongoing

Newborn Bundled Care Project (Accelerating MNCH innovations via support to the Newborn Unit of the Federal Ministry of Health)

Accelerating MNCH innovations via support to the Newborn Unit of the Federal Ministry of Health (Oct 2024 – Oct 2025)

CIHP, with funding from the Gates Foundation, is implementing the "Accelerating MNCH Innovations via Support to the Newborn Unit" grant for a 1-year duration (October 2024 - October 2025). The goal is to support the Newborn unit under the Family Health Department of the Federal Ministry of Health and Social Welfare (FMoHSW) to accelerate the adoption of high-impact innovations for improving newborn care, particularly for Small and Sick Newborns.

As part of this effort, CIHP provides technical assistance to strengthen the FMoHSW's capacity to support coordination and enhance policies and guidelines for widespread adoption. This support is crucial in advancing the newborn health agenda, ensuring the adoption of evidence-based strategies that enhance newborn survival and well-being across Nigeria.

Ongoing

REACH OUT Project

Zero-dose Immunization Initiative (Jan 2025 – Dec 2028)

REACH-OUT Project, a groundbreaking four-year (January 2025 – December 2028) multi-country initiative dedicated to transforming routine immunization access for the world's most vulnerable children. Funded by the European and Developing Countries Clinical Trials Partnership (EDCTP3), REACH-OUT targets "zero-dose" (ZD) children – those who have not received any routine vaccinations- in Nigeria, Kenya, and Rwanda, addressing critical gaps in immunization delivery where the need is most urgent.

In strong alignment with the global Immunization Agenda 2030, REACH-OUT is committed to a bold objective: to reduce the global number of zero-dose children by 50% through the development and implementation of equitable, evidence-based, and cost-effective vaccine delivery strategies.

In Nigeria, CIHP proudly serves as the implementing partner for the REACH-OUT Project, working closely with a broad spectrum of national and subnational stakeholders, including government agencies like the National Primary Health Care Development Agency, local communities, and other partners. Our dedicated efforts are driven by a singular, unwavering vision: to ensure that no child is left behind in accessing life-saving immunizations, thereby contributing to healthier, more resilient communities across Nigeria and Africa.

Ongoing

IMPAACT4HIV Project (Improved Access to AHD Care & Treatment 4 HIV)

Improved Access to AHD Care & Treatment for HIV (3.5-year regional grant)

The IMPAACT4HIV project is a 3.5-year grant, led by the Aurum Institute across six countries: South Africa, Mozambique, Democratic Republic of Congo (DRC), Côte d'Ivoire, Sierra Leone, and Nigeria, to strengthen sustainable, evidence-based interventions for improved AHD outcomes.

As the consortium lead in Nigeria, CIHP launched implementation of the IMPAACT4HIV Project in 2024, providing technical assistance to the Federal Ministry of Health to adopt and implement the World Health Organization's STOP AIDS package of care in Nigeria. The pilot is currently ongoing across 21 facilities in four states (Gombe, Kano, Lagos, and Rivers).

Through the project, CIHP supports capacity building of National and facility-level healthcare workers to advance access to quality Pediatric Advanced HIV Disease care and treatment packages for children and Adolescents in Nigeria.

Past Projects

Completed

TBLON3 Project

USAID-supported TB case-finding & system strengthening (Sep 2020 – Jan 2025)

CIHP implemented the USAID-funded TBLON3 project in Osun State, aimed at finding "missing" tuberculosis (TB) cases through innovative stakeholder engagement, expanded service coverage, mobilization of domestic resources, and the strengthening of sustainable systems for TB control. Implemented from September 2020 to January 2025, the TB-LON3 project was a comprehensive facility-based intervention in partnership with the Institute of Human Virology Nigeria (IHVN), and in collaboration with the National Tuberculosis and Leprosy Control Programme (NTBLCP), plus the Osun State TB and Leprosy Control Programme (STBLCP).

The project's impact is both clear and measurable. CIHP screened over 3.35 million clients for TB, far exceeding its original target by 74% with over 12,600 diagnosed patients started on treatment, helping to stop transmission and improve health outcomes.

A key achievement of the project was the strategic expansion of TB case-finding efforts from 40 to 122 healthcare facilities, comprising 100 public and 22 private facilities across all 30 Local Government Areas in Osun State.

Completed

Harm Reduction Intervention for People Who Inject Drugs (PWID Project)

Harm reduction for People Who Inject Drugs (Oct 2022 – Dec 2023)

From October 2022 to December 2023, CIHP implemented a Global Fund-supported Harm Reduction Intervention for People Who Inject Drugs (PWID) in nine Local Government Areas in Lagos State.

This initiative expanded CIHP's existing community-based HIV programming to address the specific health and social needs of PWID, aiming to reduce HIV infection among this population. The program provided a minimum package of services, including Needle and Syringe Programs (NSP) and community or fixed-post management of opioid overdose with naloxone. This intervention also complemented CIHP's comprehensive HIV treatment services by offering targeted interventions to minimize the adverse effects of drug use, such as wound care and identification of other STIs.

Through these efforts, CIHP reinforced its commitment to inclusive, person-centered care, ensuring the support of vulnerable populations in the national HIV and public health response.

Completed

Service Delivery Innovations Strategic Initiative (SDI SI): Evaluation Project (SDI-SI Project)

Service Delivery Innovations – Strategic Initiative (Jul 2022 – Dec 2023)

The Service Delivery Innovations – Strategic Initiative (SDI-SI) is a human resource for health (HRH) and quality improvement (QI) evaluation project implemented by CIHP in partnership with Itad and the London School of Hygiene & Tropical Medicine (LSHTM) in Jigawa State for 18 months (July 1, 2022, to December 31, 2023). The project was implemented across five African countries, Nigeria, Niger, Chad, Mali, and the Democratic Republic of Congo, through funding from the Global Fund.

In Nigeria, the SDI-SI project evaluated a quality improvement (QI) intervention led by JHPIEGO, KITS International Institute, and the World Health Organization (WHO) across 30 health facilities in Birniwa, Gwaram, and Sule-Tankarkar LGAs. This intervention was part of the Global Fund-supported initiative, Quality Improvement and Leadership and Management Strengthening through Technical Assistance.

CIHP's evaluation employed a mixed-methods approach, combining a health facility survey, routine health data abstraction, and a detailed process evaluation. The process evaluation included direct observations (check-ins) and in-depth interviews to assess both the implementation and impact of the intervention.

The evaluation sought to determine the extent to which the SDI-SI intervention improved the quality of care for key diseases, while also providing insights into the mechanisms that drove or hindered change.

Completed

Group Antenatal Care (GANC Project)

Group Antenatal Care model (Jan 2020 – Apr 2022)

The Group Antenatal Care (G-ANC) project was focused on increasing the proportion of pregnant women in Kaduna State, achieving at least eight antenatal care contacts by 25% above baseline within 27 months.

Funded by the Bill & Melinda Gates Foundation through TA Connect and implemented by CIHP, the project supported the Kaduna State Government to adopt, adapt, and sustain the Group Antenatal Care model as an alternative to the traditional individual ANC approach.

The project was implemented from January 2020 to April 2022 across 485 health facilities. It promoted peer support and improved quality of care. Strong partnerships with government, Reproductive, Maternal and Child Health (RMCH) task teams, and community stakeholders ensured local ownership and integration into routine maternal health services.

Completed

LEOPOD Project

Leveraging Positive Deviance to increase vaccination demand (May 2019 – Apr 2021)

CIHP implemented the LEOPOD (Leveraging Enablers of Positive Deviancy to Increase Demand for Vaccination) project, an innovative initiative designed to improve routine immunization uptake in underserved communities. Funded by the Bill & Melinda Gates Foundation under its Grand Challenges Explorations (GCE) initiative, the project spanned May 2019 to April 2021.

LEOPOD was implemented in partnership with the State Ministries of Health, State Emergency Routine Immunization Coordination Centres (SERICC), and other critical stakeholders in four Local Government Areas (LGAs), two each in Niger and Gombe States. The project focused on addressing behavioural and social barriers that contribute to vaccine hesitancy in low-resource settings.

Using the Positive Deviance (PD) approach, LEOPOD identified and leveraged uncommon yet successful practices adopted by certain caregivers within these communities who were ensuring full immunization of their children, despite facing similar constraints as others. By highlighting and amplifying these community-driven solutions, the project fostered local ownership, rebuilt trust in vaccination programs, and created a sustainable model for increasing immunization demand.

The outcomes of LEOPOD demonstrate that empowering communities through contextually grounded, evidence-based strategies can drive significant improvements in routine immunization coverage.